TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MYGN

Myriad Genetics Inc

Healthcare · Diagnostics & Research

4.50$ +11.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Myriad Genetics Inc (MYGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 639 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MYGN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,271 1,276 1,268 1,224 1,228 1,229 1,219 1,174 1,574 1,557 1,557 1,563 1,591 1,578 1,447 1,405 1,445 1,419 1,337 1,360 1,336 1,321 1,255 1,210 1,212 1,199 1,169 1,187 1,149 1,147 1,111 1,085 1,081 1,028 1,006 677 728 707 674 639
323 342 348 317 326 327 332 326 342 337 343 349 330 365 355 332 395 389 329 539 499 485 427 367 352 275 262 294 265 314 290 292 293 298 287 284 345 333 313 289
87 108 124 102 88 89 97 111 93 91 85 93 90 81 121 164 118 117 149 118 295 257 165 105 111 57 54 103 76 132 97 92 100 102 92 74 145 150 124 115
148 163 172 151 148 144 157 181 168 165 150 137 143 142 182 218 160 151 176 164 366 339 268 205 193 115 79 122 86 141 104 97 100 102 92 74 145 150 124 115
103 112 119 111 120 127 127 102 123 123 147 139 122 122 105 71 87 92 97 95 94 91 102 110 102 102 119 112 115 114 118 118 126 121 120 137 118 115 124 110
54 51 47 42 39 38 33 34 36 33 32 31 28 28 31 29 27 27 25 18 19 15 16 15 20 20 22 23 25 22 25 26 26 28 28 29 32 31 28 31
57 55 53 51 50 48 48 43 60 59 59 57 55 37 37 103 37 100 45 130 127 125 117 136 178 187 203 219 – – – – – – – – – – – –
313 315 315 316 319 319 320 319 413 413 416 417 416 408 327 328 328 329 328 240 240 239 239 238 237 287 287 287 287 287 287 286 286 286 286 52 52 52 47 47
521 506 498 492 484 475 467 455 734 718 700 685 668 654 620 605 591 577 560 427 415 404 394 382 371 380 369 359 357 350 341 320 313 262 258 170 163 153 146 139
536 543 520 447 358 314 270 209 471 493 476 474 517 501 480 486 535 539 462 458 367 353 305 263 295 313 334 452 466 363 351 345 350 327 301 289 355 339 336 335
275 83 222 218 139 159 94 102 108 113 109 118 115 112 113 147 134 146 149 271 203 204 166 120 129 137 143 221 209 156 146 149 154 164 151 200 148 134 130 131
199 – 64 66 60 61 64 68 76 74 79 79 13 13 13 14 14 14 14 117 13 13 13 13 14 14 15 17 18 16 14 13 14 13 11 68 7.9 6.9 7.1 7.3
20 23 27 22 23 25 20 26 24 32 24 33 24 21 30 22 19 21 21 29 16 30 27 22 30 29 37 40 34 26 33 33 30 32 28 31 32 30 33 30
0.0 204 167 99 74 43 69 9.3 258 273 263 234 225 225 225 224 225 225 154 – – – – – – – – 38 39 39 39 39 39 40 59 – 120 120 120 121
736 733 748 778 871 914 948 965 1,102 1,064 1,082 1,089 1,075 1,077 967 918 909 880 875 903 969 968 950 947 917 886 835 735 683 783 760 741 732 701 705 388 373 368 337 304
-87 -86 -81 -68 13 45 56 53 53 23 30 26 5.0 -3.3 -119 -174 -189 -233 -267 -271 -247 -254 -275 -289 -324 -366 -421 -537 -598 -630 -656 -692 -714 -757 -757 -1,087 -1,115 -1,123 -1,157 -1,200
69 68 68 69 70 72 72 73 73 77 75 75 74 74 75 75 75 75 76 77 82 80 80 80 81 82 81 82 82 86 90 91 91 91 91 93 93 93 94 95

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?